Amgen has announced a strategic expansion of its distribution model, allowing certain prescription medications to be sold directly to consumers. This initiative follows increasing pressure from President Donald Trump to encourage direct patient engagement with medication. Dr. Oz has also been advocating for the use of GLP-1 agonists – a class of medications designed to promote weight loss – as a potential treatment for obesity. This move represents a shift in how pharmaceutical companies approach drug sales, potentially altering market dynamics and patient access.
Credits: US Top News and Analysis
